Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.

類似資料

• Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
  著者:: Scriba, T, 等
  出版事項: (2011)
• A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
  著者:: Scriba, T, 等
  出版事項: (2012)
• Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
  著者:: Scriba, T, 等
  出版事項: (2010)
• The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
  著者:: Tameris, M, 等
  出版事項: (2014)
• Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
  著者:: Mcshane, H, 等
  出版事項: (2016)